F.D.A. Rejects Closely Watched Lung Cancer Drug From China

Written by

in

The New York Times – Business:

The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.

This post first appeared in The New York Times – Business. Read the original article.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *